Alkermes (ALKS) Interest & Investment Income (2010 - 2026)
Alkermes' (ALKS) quarterly Interest & Investment Income came in at $5.3 million in Q2 2026, down 51.81% year-over-year from $11.1 million in Q2 2025, and up 1040.85% quarter-over-quarter from -$568000.0 in Q1 2026.
Analysis
Alkermes (ALKS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Interest & Investment Income for 17 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 51.81% year-over-year to $5.3 million in Q2 2026; TTM through Jun 2026 was $28.8 million, a 14.94% decrease from a year earlier, with the FY2025 full-year figure at $45.3 million, up 6.72% from the prior year.
- Interest & Investment Income was $5.3 million for Q2 2026 at Alkermes, up from -$568000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $16.7 million in Q4 2022 and troughed at -$4.5 million in Q1 2022.
- A 5-year average of $5.1 million and a median of $4.1 million in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 728.68% in 2022 and soared 100718.18% in 2025, its largest moves.
- Over 5 years, Interest & Investment Income stood at $16.7 million in 2022, then slumped by 41.77% to $9.7 million in 2023, then climbed by 16.94% to $11.4 million in 2024, then gained by 6.4% to $12.1 million in 2025, then tumbled by 55.94% to $5.3 million in 2026.
- The last three Interest & Investment Income figures came in at $5.3 million (Q2 2026), -$568000.0 (Q1 2026), and $12.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 443.49 Bn | 436.92 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 365.35 Bn | 358.21 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.75 Bn | 259.06 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.55 Bn | 146.85 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.39 Bn | 45.01 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.35 Bn | 20.82 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.57 Bn | 18.91 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Alkermes | 7.57 Bn | 6.92 Bn | 397.90 Mn | 5.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Mar 31, 2026 | -568,000.00 |
| Dec 31, 2025 | 12.13 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Jun 30, 2025 | 11.09 Mn |
| Mar 31, 2025 | 512,000.00 |
| Dec 31, 2024 | 11.40 Mn |
| Sep 30, 2024 | 10.92 Mn |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | -491,000.00 |
| Dec 31, 2023 | 9.75 Mn |
| Sep 30, 2023 | 9.37 Mn |
| Jun 30, 2023 | 692,000.00 |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 16.74 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Mar 31, 2022 | -4.51 Mn |
| Dec 31, 2021 | 453,000.00 |
| Sep 30, 2021 | 468,000.00 |